Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-01
DOI
10.3389/fphar.2017.00782
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages
- (2016) Khatuna Gabunia et al. AMERICAN JOURNAL OF PATHOLOGY
- Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis
- (2016) Héctor Rincón-Arévalo et al. ATHEROSCLEROSIS
- Irgm1 promotes M1 but not M2 macrophage polarization in atherosclerosis pathogenesis and development
- (2016) Shaohong Fang et al. ATHEROSCLEROSIS
- Macrophage Phenotype and Function in Different Stages of Atherosclerosis
- (2016) Ira Tabas et al. CIRCULATION RESEARCH
- Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
- (2016) Sebastian Zimmer et al. Science Translational Medicine
- Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation
- (2016) Diego Saita et al. Scientific Reports
- Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice
- (2015) Livan Delgado-Roche et al. FREE RADICAL BIOLOGY AND MEDICINE
- Recent insights into the cellular biology of atherosclerosis
- (2015) Ira Tabas et al. JOURNAL OF CELL BIOLOGY
- Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice
- (2014) Tomoyuki Kita et al. CARDIOVASCULAR RESEARCH
- Mechanisms That Regulate Macrophage Burden in Atherosclerosis
- (2014) Gwendalyn J Randolph CIRCULATION RESEARCH
- Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
- (2014) Peter Libby et al. CIRCULATION RESEARCH
- Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody
- (2014) Yosdel Soto et al. mAbs
- Regression of Atherosclerosis: Insights from Animal and Clinical Studies
- (2014) Jonathan E. Feig Annals of Global Health
- Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
- (2013) Peter Libby et al. IMMUNITY
- Immunological aspects of atherosclerosis
- (2013) S. Garrido-Urbani et al. Seminars in Immunopathology
- Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans
- (2012) Yosdel Soto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Induction of Anti-Anti-Idiotype Antibodies Against Sulfated Glycosaminoglycans Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2012) Víctor Brito et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice
- (2012) Olivier Herbin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Animal Models of Atherosclerosis
- (2012) Godfrey S. Getz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Emerging biomarkers and intervention targets for immune-modulation of atherosclerosis – A review of the experimental evidence
- (2012) Harry Björkbacka et al. ATHEROSCLEROSIS
- Regression of Atherosclerosis in Apolipoprotein E-Deficient Mice is Feasible Using High-Dose Angiotensin Receptor Blocker, Candesartan
- (2012) Kaori Hayashi et al. Journal of Atherosclerosis and Thrombosis
- Orally Administered Eicosapentaenoic Acid Induces Rapid Regression of Atherosclerosis Via Modulating the Phenotype of Dendritic Cells in LDL Receptor-Deficient Mice
- (2011) Kenji Nakajima et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe–/– mice during disease regression
- (2011) Stephane Potteaux et al. JOURNAL OF CLINICAL INVESTIGATION
- The immune system in atherosclerosis
- (2011) Göran K Hansson et al. NATURE IMMUNOLOGY
- Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
- (2011) P. Fogelstrand et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis
- (2010) Roland Klingenberg et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Adaptive immunity and atherosclerosis
- (2009) John Andersson et al. CLINICAL IMMUNOLOGY
- Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression
- (2008) Cecilia M. Devlin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cytokines and atherosclerosis: a comprehensive review of studies in mice
- (2008) R. Kleemann et al. CARDIOVASCULAR RESEARCH
- Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
- (2008) James A. Shaw et al. CIRCULATION RESEARCH
- Atheroprotective Effects of HDL: Beyond Reverse Cholesterol Transport
- (2008) Edward Fisher et al. CURRENT DRUG TARGETS
- Rapid regression of atherosclerosis: insights from the clinical and experimental literature
- (2008) Kevin Jon Williams et al. Nature clinical practice. Cardiovascular medicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started